Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Opt Express ; 31(7): 11292-11307, 2023 Mar 27.
Artículo en Inglés | MEDLINE | ID: mdl-37155768

RESUMEN

Randomness, mainly in the form of random numbers, is the fundamental prerequisite for the security of many cryptographic tasks. Quantum randomness can be extracted even if adversaries are fully aware of the protocol and even control the randomness source. However, an adversary can further manipulate the randomness via tailored detector blinding attacks, which are hacking attacks suffered by protocols with trusted detectors. Here, by treating no-click events as valid events, we propose a quantum random number generation protocol that can simultaneously address source vulnerability and ferocious tailored detector blinding attacks. The method can be extended to high-dimensional random number generation. We experimentally demonstrate the ability of our protocol to generate random numbers for two-dimensional measurement with a generation speed of 0.1 bit per pulse.

2.
Entropy (Basel) ; 25(4)2023 Apr 11.
Artículo en Inglés | MEDLINE | ID: mdl-37190430

RESUMEN

In the Quantum Key Distribution (QKD) network, authentication protocols play a critical role in safeguarding data interactions among users. To keep pace with the rapid advancement of QKD technology, authentication protocols must be capable of processing data at faster speeds. The Secure Hash Algorithm (SHA), which functions as a cryptographic hash function, is a key technology in digital authentication. Irreducible polynomials can serve as characteristic functions of the Linear Feedback Shift Register (LFSR) to rapidly generate pseudo-random sequences, which in turn form the foundation of the hash algorithm. Currently, the most prevalent approach to hardware implementation involves performing block computations and pipeline data processing of the Toeplitz matrix in the Field-Programmable Gate Array (FPGA) to reach a maximum computing rate of 1 Gbps. However, this approach employs a fixed irreducible polynomial as the characteristic polynomial of the LFSR, which results in computational inefficiency as the highest bit of the polynomial restricts the width of parallel processing. Moreover, an attacker could deduce the irreducible polynomials utilized by an algorithm based on the output results, creating a serious concealed security risk. This paper proposes a method to use FPGA to implement variational irreducible polynomials based on a hashing algorithm. Our method achieves an operational rate of 6.8 Gbps by computing equivalent polynomials and updating the Toeplitz matrix with pipeline operations in real-time, which accelerates the authentication protocol while also significantly enhancing its security. Moreover, the optimization of this algorithm can be extended to quantum randomness extraction, leading to a considerable increase in the generation rate of random numbers.

3.
Front Neurol ; 13: 900438, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35812117

RESUMEN

Introduction: Asthma and stroke share many risk factors. Previous meta-analysis has indicated that asthma is associated with an increased risk of stroke. However, this study were limited by the small number of articles included and the lack of subgroup analyses of different stroke types and different populations. This meta-analysis aimed to synthesize evidence systematically to investigate the impact of asthma on stroke. Methods: We searched Medline (via PubMed), Web of Science and EMBASE databases and manually identified eligible studies (inception dates to December 25, 2021) that analyzed the association between asthma and stroke. We conducted quality assessment to evaluate the risk of bias of studies and sensitivity analyses to test the robustness of results. Results: We included 8 cohort studies and 10 cross-sectional studies comprised 3,011,016 participants. We found patients with asthma had a higher risk of stroke than patients without asthma [relative risk (RR): 1.34, 95% confidence interval (CI): 1.21-1.47]. Moreover, asthma significantly increased the risk of ischemic stroke (RR: 1.25, 95% CI: 1.06-1.47) without increasing the risk of hemorrhagic stroke (RR: 1.08, 95% CI: 0.87-1.34). Asthma increased the risk of stroke in both men (RR: 1.20, 95% CI: 1.10-1.32) and women (RR: 1.29, 95% CI: 1.12-1.48) with no significant difference between the sexes. We also found that patients with inactive asthma, child-onset asthma, or no smoking history did not have an increased risk of stroke. Conclusions: These results supported the finding that asthma could significantly increase the risk of stroke, but this impact was not consistent in different populations. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=290745, identifier: CRD42021290745.

4.
J Int Med Res ; 46(12): 5237-5244, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30319010

RESUMEN

OBJECTIVE: A rabbit model was used to evaluate the effects of bone-cemented hip arthroplasty on distal femoral blood flow and metabolism relative to that of the non-cemented contralateral leg. METHODS: The marrow cavity of the right hind femur was filled with bone cement. At each of the following time points, rabbits were randomly selected to receive an injection of one dose of 99mTc-methylene diphosphonate and then immediately scanned using a gamma camera: immediately postoperatively and at 4 and 8 weeks postoperatively. A BL-410 model biofunction experimental system was used to analyze the acquired images and determine the radioactive counts of each hind leg. RESULTS: The X-ray and photographic images of the right femoral bones confirmed successful filling of the marrow cavity with bone cement. The radioactive counts were significantly lower in the experimental than control legs at each time point. The ratio of the radioactive count of the experimental to control leg increased considerably at each time point, but each ratio was <1. CONCLUSION: Blocking the proximal femoral medullary cavity with bone cement was associated with significant lowering of the blood circulation of the femur and marrow, decreasing the distal femoral blood flow and bone metabolic rate.


Asunto(s)
Cementos para Huesos/efectos adversos , Fémur/irrigación sanguínea , Fémur/efectos de los fármacos , Hemodinámica/efectos de los fármacos , Animales , Artroplastia de Reemplazo de Cadera/métodos , Fémur/diagnóstico por imagen , Fémur/cirugía , Humanos , Modelos Animales , Conejos , Radiografía , Radiofármacos/administración & dosificación , Radiofármacos/metabolismo , Medronato de Tecnecio Tc 99m/administración & dosificación , Medronato de Tecnecio Tc 99m/metabolismo , Tomografía Computarizada de Emisión
5.
Mol Med Rep ; 17(1): 422-427, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29115446

RESUMEN

The present study aimed to investigate the effect of Dermatopontin (DPT) gene silencing on the apoptosis and proliferation of osteosarcoma MG­63 cells. Three eukaryotic expression vectors of short hairpin (sh)RNA fragments targeting different loci of DPT were designed and transfected into an osteosarcoma cell line MG­63. The cells were assigned to a blank, shRNA­control, DPT­shRNA­a, DPT­shRNA­b or DPT­shRNA­c group. The shRNA with the highest silencing efficiency was screened using reverse transcription­quantitative polymerase chain reaction and western blotting. The screened shRNA was transfected into MG­63 cells. The proliferation, cell cycle and apoptosis of MG­63 cells were measured using a Cell Counting Kit­8 assay, flow cytometry and Annexin V­fluorescein isothiocyanate assay. The recombinant plasmids containing DPT shRNA were successfully constructed. DPT gene silencing was able to significantly reduce the proliferation rate of MG­63 cells (P<0.05). The proportion of cells in the G0/G1 phase and in the G2/M phase increased significantly (both P<0.05), while the proportion of cells in the S phase decreased (P<0.05). Furthermore, the cell apoptosis rate increased significantly (P<0.05). These results demonstrate that DPT gene silencing is able to reduce the proliferation of MG­63 cells, slow down cell cycle progression and promote apoptosis, hence may become a novel target for the treatment of osteosarcoma.


Asunto(s)
Neoplasias Óseas/genética , Proteoglicanos Tipo Condroitín Sulfato/genética , Proteínas de la Matriz Extracelular/genética , Silenciador del Gen , Osteosarcoma/genética , Apoptosis/genética , Ciclo Celular/genética , Línea Celular Tumoral , Proliferación Celular , Regulación Neoplásica de la Expresión Génica , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA